Related Experiment Video
Updated: Aug 8, 2026

08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Dornase alpha and survival of patients with cystic fibrosis
1Roche Products Ltd, Welwyn Garden City, Hertfordshire.
Hospital Medicine (London, England : 1998)
|February 3, 2000
Abstract:
Dornase alpha can offer substantial clinical benefits to cystic fibrosis patients, but its long-term impact is as yet unknown. This article attempts to model the impact of continuous dornase alpha use on patient survival and its cost implications for the health-care provider.

